(Q44304513)
Statements
A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptine in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level (English)
Mohammad Ebrahim Parsanezhad
Bahia Namavar Jahromi
1 November 2002